# Phase 1 Parkinson Disease trials recruiting: 43 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 43 trials in phase 1 for Parkinson Disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 1 Parkinson Disease trials: 43 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-1/parkinson-disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 43
- Recruiting or not yet: 43
- Read on: November 19, 2026

## Trials

The 25 newest of 43, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 3, 2026 | NCT07914387 | Stanford University Neurofiber Study | Stanford University | Phase 1 | Not yet recruiting | PARKINSON DISEASE (Disorder) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914387) |
| October 26, 2026 | NCT07896187 | A Phase 1 Study of NCR201 in Parkinson's Disease Patients With Prior DBS | Nuwacell Biotechnologies Co., Ltd. | Phase 1 | Not yet recruiting | PARKINSON DISEASE (Disorder), Cell Therapy, Human Induced Pluripotent Stem Cells, Deep Brain Stimulation, Phase 1... | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896187) |
| October 19, 2026 | NCT07880379 | MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and \[¹⁸F\]MK-0947 in... | XingImaging, LLC | Phase 1 | Recruiting | Parkinsons Disease (PD), Healthy Elderly Volunteers | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880379) |
| September 24, 2026 | NCT07840027 | Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease | Tridem Bioscience FlexCo | Phase 1 | Recruiting | Parkinson Disease (PD), Idiopathic Parkinson's Disease | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840027) |
| August 20, 2026 | NCT07777484 | An Unblinded, Single Arm, Pilot Observational Study to Test the Safety, Tolerability, Immunogenicity and the Biological Effects of TRB-001... | Tridem Bioscience FlexCo | Phase 1 | Recruiting | Parkinson's Disease | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777484) |
| July 22, 2026 | NCT07718659 | ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease | Qianfoshan Hospital | Phase 1 | Not yet recruiting | Parkinson's Disease (PD), Parkinsonian Disorders | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07718659) |
| June 24, 2026 | NCT07666022 | A Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study) | University of Shizuoka | Phase 1 | Recruiting | Healthy Adult Male, PARKINSON DISEASE (Disorder) | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07666022) |
| June 5, 2026 | NCT07630545 | A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients. | Mission Therapeutics | Phase 1 | Recruiting | Parkinson's Disease (PD), Mild to Moderate Parkinson's Disease, Early Stage Parkinson's Disease | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630545) |
| May 22, 2026 | NCT07604116 | A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers... | Synusight Biotech (Shanghai) Co., Ltd. | Phase 1 | Recruiting | Multiple System Atrophy (MSA), Parkinson's Disease (PD) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07604116) |
| May 7, 2026 | NCT07572071 | Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease | Royan Institute | Phase 1 | Recruiting | Parkinson Disease (PD) | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07572071) |
| April 29, 2026 | NCT07557706 | Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease | University of Alabama at Birmingham | Phase 1 | Recruiting | PARKINSON DISEASE (Disorder) | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07557706) |
| April 24, 2026 | NCT07550374 | Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have... | iRegene Therapeutics Co., Ltd. | Phase 1 | Not yet recruiting | Parkinson's Disease (PD) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07550374) |
| April 22, 2026 | NCT07543861 | A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease | University of Michigan | Phase 1 | Recruiting | Parkinson Disease | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07543861) |
| April 7, 2026 | NCT07513441 | A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD) | H. Lundbeck A/S | Phase 1 | Recruiting | Parkinson Disease | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07513441) |
| February 20, 2026 | NCT07422675 | SAD Study in Patients With Parkinson's Disease and Motor Fluctuations | Serina Therapeutics | Phase 1 | Recruiting | PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07422675) |
| January 27, 2026 | NCT07371338 | Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients | Innopeutics Corporation | Phase 1 | Recruiting | Parkinson Disease, Parkinson's Disease | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07371338) |
| January 14, 2026 | NCT07340073 | Coordinated Reset Deep Brain Stimulation for Parkinson's Disease | University of Minnesota | Phase 1 | Not yet recruiting | Parkinson's Disease (PD), Deep Brain Stimulation | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07340073) |
| December 5, 2025 | NCT07267065 | AAV2-hAADC for Parkinson's Disease (PDCS-01) | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Parkinson's Disease (PD), Early Onset Parkinson Disease | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07267065) |
| November 18, 2025 | NCT07232147 | Clinical Research on Stem Cell Therapy for Parkinson's Disease | Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. | Phase 1 | Not yet recruiting | Parkinson Disease (PD), Neurodegenerative Diseases, Movement Disorders | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07232147) |
| October 14, 2025 | NCT07216066 | First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD) | Regeneron Pharmaceuticals | Phase 1 | Recruiting | Parkinsons Disease | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07216066) |
| October 8, 2025 | NCT07212088 | Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease | iCamuno Biotherapeutics Ltd. | Phase 1 | Not yet recruiting | Parkinson Disease | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07212088) |
| September 12, 2025 | NCT07170475 | A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease | Fujita Health University | Phase 1 | Recruiting | Parkinson's Disease (PD) | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07170475) |
| September 5, 2025 | NCT07157345 | Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease | Ruijin Hospital | Phase 1 | Recruiting | Parkinson Disease (PD) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07157345) |
| July 14, 2025 | NCT07064005 | Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients. | Sponsor not shown (see the record) | Phase 1 | Recruiting | Parkinsons Disease (PD) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07064005) |
| May 30, 2025 | NCT06997484 | First-in-Human Single and Multiple Dose of HL-400 | Highlightll Pharmaceutical (USA) LLC | Phase 1 | Recruiting | Parkinson Disease | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06997484) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Nuwacell Biotechnologies Co., Ltd. | 2 |
| iCamuno Biotherapeutics Ltd. | 2 |
| Xuanwu Hospital, Beijing | 2 |
| Tridem Bioscience FlexCo | 2 |
| National Institute of Mental Health (NIMH) | 1 |
| University of Minnesota | 1 |
| Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. | 1 |
| The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 1 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 1 |
| Innopeutics Corporation | 1 |
| Longevity Biotech Australia Pty Ltd (subsidiary) | 1 |
| Serina Therapeutics | 1 |
| Synusight Biotech (Shanghai) Co., Ltd. | 1 |
| The Foundation for Orthopaedics and Regenerative Medicine | 1 |
| Taiwan Mitochondrion Applied Technology Co., Ltd. | 1 |
| Gain Therapeutics, Inc. | 1 |
| Ruijin Hospital | 1 |
| XingImaging, LLC | 1 |
| Stanford University | 1 |
| Prevail Therapeutics | 1 |
| Highlightll Pharmaceutical (USA) LLC | 1 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 1 |
| Fujita Health University | 1 |
| University of California, San Diego | 1 |
| Qianfoshan Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 18 |
| China | 12 |
| Australia | 4 |
| Japan | 4 |
| Netherlands | 2 |
| Austria | 2 |
| Germany | 2 |
| United Kingdom | 2 |
| Canada | 1 |
| South Korea | 1 |
| Taiwan | 1 |
| Greece | 1 |
| Iran | 1 |
| France | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Public relations firms in the United States](https://specstream.ai/data/businesses/public-relations-firms/united-states)
- [Refinishing companies in the United States](https://specstream.ai/data/businesses/refinishing-companies/united-states)
- [Salad bars in the United States](https://specstream.ai/data/businesses/salad-bars/united-states)
- [Sheet metal fabricators in the United States](https://specstream.ai/data/businesses/sheet-metal-fabricators/united-states)
- [South African restaurants in the United States](https://specstream.ai/data/businesses/south-african-restaurants/united-states)
- [Stock brokers in the United States](https://specstream.ai/data/businesses/stock-brokers/united-states)
